H. Bartsch
Division of Toxicology and Cancer Risk Factors
German Cancer Research Center (DKFZ)
Heidelberg
Germany
Name/email consistency: high
- Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Bartsch, H., Nair, U., Risch, A., Rojas, M., Wikman, H., Alexandrov, K. Cancer Epidemiol. Biomarkers Prev. (2000)
- Lack of evidence for tamoxifen- and toremifene-DNA adducts in lymphocytes of treated patients. Bartsch, H., Phillips, D.H., Nair, J., Hewer, A., Meyberg-Solomeyer, G., Grischke, E.M. Carcinogenesis (2000)
- Studies on biomarkers in cancer etiology and prevention: a summary and challenge of 20 years of interdisciplinary research. Bartsch, H. Mutat. Res. (2000)
- New DNA-based biomarkers for oxidative stress and cancer chemoprevention studies. Bartsch, H., Nair, J. Eur. J. Cancer (2000)
- Genetic cancer susceptibility and DNA adducts: studies in smokers, tobacco chewers, and coke oven workers. Bartsch, H., Rojas, M., Nair, U., Nair, J., Alexandrov, K. Cancer Detect. Prev. (1999)
- Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers. Bartsch, H., Nair, J., Owen, R.W. Carcinogenesis (1999)
- The role of individual susceptibility in cancer burden related to environmental exposure. Bartsch, H., Hietanen, E. Environ. Health Perspect. (1996)